Jan 12, 2026 8:00 am EST Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO™ (tabelecleucel)
Nov 12, 2025 9:00 am EST Atara Biotherapeutics Announces Third Quarter Financial Results and Operational Progress